Alzheimer's disease amyloid-beta peptide modulates apolipoprotein E isoform specific receptor binding

Eugene Hone, I.J. Martins, M. Jeoung, T.H. Ji, S.E. Gandy, Ralph Martins

Research output: Contribution to journalArticlepeer-review

24 Citations (Scopus)


The major protein component of the extracellular deposits in Alzheimer's disease (AD) is a 4 kDa peptide termed amyloid-beta (A beta). This peptide is known to bind apolipoprotein E (apoE), a key mediator of lipoprotein transport, in an isoform specific manner. Whilst these isoform specific effects on apoE are well recognized, the functional significance of this interaction is poorly understood. Here, we investigated the influence of A beta on apoE-mediated lipoprotein binding to cells using fluorescently tagged lipoprotem-like emulsions. Using this approach, we demonstrate that A beta enhanced the normally poor binding of apoE2 lipoprotein-like particles to fibroblasts in culture, whilst markedly reducing the binding of apoE3 and apoE4. This suggests that the action of apoE isoforms on cellular lipoprotein or cholesterol metabolism is differentially modulated by A beta. This also suggests that A beta may also compromise apoE function in the Alzheimer disease affected brain.
Original languageEnglish
Pages (from-to)303-314
JournalJournal of Alzheimer's Disease
Issue number4
Publication statusPublished - 2005


Dive into the research topics of 'Alzheimer's disease amyloid-beta peptide modulates apolipoprotein E isoform specific receptor binding'. Together they form a unique fingerprint.

Cite this